Research & Development



彩票软件下载cc彩 口角邊常添幾道酸甜的紋路,可以幫助彼此咀嘴生活。何不默認這一點︰在迷惘中人最應該有笑,這種笑,雖然是斂住神經,斂住肌肉,僅是毅力的後背,它卻是必需的,如同保護色對于許多生物,是必需的一樣。彩票软件下载官网下载 “這女人算好看不?”正规彩票app大全

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo